CryoLife, Inc.
14
0
1
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.3%
2 terminated/withdrawn out of 14 trials
84.6%
-1.9% vs industry average
7%
1 trials in Phase 3/4
36%
4 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Cryopreserved Saphenous Vein Allograft in Patients With Critical Limb Ischemia for Peripheral Revascularization
Role: lead
Hemodialysis Reliable Outflow (HeRO) Vascular Access Patency Study
Role: collaborator
Data Collection Registry of the HeRO Graft for End Stage Renal Disease Patients Receiving Hemodialysis
Role: collaborator
Post-surgical Aortic Hemodynamics After Aortic Valve Replacement
Role: lead
CardioGenesis Transmyocardial Revascularization 1-Year Follow-Up Study
Role: lead
BioGlue as an Adjunct for Structural Repair and Hemostasis in Chinese Acute Type A Aortic Dissections Patients
Role: lead
NeoPatch Used as Adjunct in Foot and Ankle Tendon Surgery
Role: lead
Effectiveness of BioFoam® Surgical Matrix to Improve Hemostasis During Liver Resection
Role: collaborator
HeRO Graft Compared to Permanent Catheters for End Stage Renal Disease (ESRD) Patients Receiving Hemodialysis
Role: collaborator
CryoValve SG Pulmonary Human Heart Valve Post Clearance Study
Role: lead
CryoValve® SG Aortic Human Heart Valve Combination Study
Role: lead
Adjunctive Application of BioFoam Surgical Matrix in Liver Surgery
Role: lead
PerClot to Control Bleeding in Endoscopic Sinus Surgery
Role: collaborator
Saphenous Vein Allografts for Coronary Bypass
Role: lead
All 14 trials loaded